Thomas McGuire

Premium Transparency in the Medicare Advantage Market: Implications for Premiums, Benefits, and Efficiency

Year: 2014
Journal: No Journal Matched
Authors: Karen Stockley; Thomas McGuire; Christopher Afendulis; Michael E. Chernew

Do Reverse Payment Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?

Year: 2014
Journal: International Journal of the Economics of Business
Authors: Keith M. Drake; Martha A. Starr; Thomas McGuire

Improving Risk Equalization with Constrained Regression

Year: 2015
Journal: No Journal Matched
Authors: Richard van Kleef; Thomas McGuire; Rene van Vliet; Wynand van de Ven

Premium Levels and Demand Response in Health Insurance: Relative Thinking and Zero-Price Effects

Year: 2017
Journal: No Journal Matched
Authors: Rudy Douven; Ron van der Heijden; Thomas McGuire; Frederik T. Schut

The Comparative Advantage of Medicare Advantage

Year: 2018
Journal: American Journal of Health Economics
Authors: Joseph P. Newhouse; Mary Beth Landrum; Mary Price; J. Michael McWilliams; John Hsu; Thomas McGuire

No Free Launch: At-Risk Entry by Generic Drug Firms

Year: 2021
Journal: International Journal of the Economics of Business
Authors: Keith M. Drake; Robert He; Thomas McGuire; Alice K. Ndikumana

Most-Favored Entry Clauses in Drug Patent Litigation Settlements as a Potential Reverse Payment

Year: 2022
Journal: No Journal Matched
Authors: Keith M. Drake; Thomas McGuire

The Simple Math of Royalties and Drug Competition During the 180-Day Generic Exclusivity Period

Year: 2023
Journal: No Journal Matched
Authors: Keith M. Drake; Thomas McGuire

Combining Risk Adjustment with Risk Sharing in Health Plan Payment Systems: Private Health Insurance in Australia

Year: 2023
Journal: No Journal Matched
Authors: Josefa Henriquez; Richard C. van Kleef; Andrew Matthews; Thomas McGuire; Francesco Paolucci